[email protected]
CAS 536721-25-2 N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester molecular structure lightbox
CAS RN: 536721-25-2

N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250807 1g / 5g / 10g Out of stock 8-10 business days Inquiry
  • Product code: SSC-161041
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 5g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 536721-25-2
Pack Size Recorded Purity Available Qty Ship From Inquiry
5g ≥95% 0 Out of Stock Beijing Inquiry

536721-25-2 / (4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid

Standard CAS: 536721-25-2 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
536721-25-2
Multi CAS
Yes
Molecular Formula
C25H47NO5
Molecular Weight
441.600000
Exact Mass
441.345424
InChI
InChI=1S/C25H47NO5/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22(27)26-21(19-20-23(28)29)24(30)31-25(2,3)4/h21H,5-20H2,1-4H3,(H,26,27)(H,28,29)/t21-/m0/s1
InChIKey
LXTVAOWDMLOIBO-NRFANRHFSA-N

Computed Properties

Structural Parameters

Heavy atom count
31
Fraction Csp3
0.88
Rotatable bonds
19
H-bond acceptors
4
H-bond donors
2
Molar refractivity
124.96
TPSA
92.7

LogP / Solubility

WLOGP
6.16
MLOGP
5.45
XLogP3
7.7
Consensus LogP
6.44
Log S (ESOL)
-5.2
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.63
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.92
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.04

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3

Customers Also Viewed

Get In Touch

Contact Us